Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review

-acetylcysteine was investigated in two clinical trials and one RCT and was minimally effective in the RCT and in one clinical study. Our review did not identify available studies of local alternative otoprotective agents that could reliably replace systemic STS in terms of safety and efficacy for pediatric patients. Further research on the optimal dosage, delivery method, and timing of otoprotective agents is needed.

Authors

Institutions

Publication Details

Journal
Drug Delivery
Published
2026-05-01
DOI
https://doi.org/10.1080/10717544.2026.2665892
Primary Topic
Hearing, Cochlea, Tinnitus, Genetics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review

Vassilios Papadakis, Brice Fresneau, Penelope Brock, Rudolf Maibach et al.
Drug Delivery
Hearing, Cochlea, Tinnitus, Genetics
article

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review

Vassilios Papadakis, Brice Fresneau, Penelope Brock, Rudolf Maibach, Archie Bleyer, Martine van Grotel, Éric Bouffet, Michael Sullivan, Allison F. O’Neill, Kaukab Rajput, James I. Geller, Per Kogner, Gareth J. Veal, Nienke Streefkerk, Amirhossein Masroor, Alwin D R Huitema, Kristin Knight, Marc Ansari, Marry M Van Den Heuvel-Eibrink, Alexander E Hoetink
article en

Abstract

-acetylcysteine was investigated in two clinical trials and one RCT and was minimally effective in the RCT and in one clinical study. Our review did not identify available studies of local alternative otoprotective agents that could reliably replace systemic STS in terms of safety and efficacy for pediatric patients. Further research on the optimal dosage, delivery method, and timing of otoprotective agents is needed.

Drug DeliveryVol. 33(1)
University of Geneva (CH), Royal Children's Hospital (AU), Karolinska University Hospital (SE), Inserm (FR), Oregon Health & Science University (US), Utrecht University (NL), Great Ormond Street Hospital for Children NHS Foundation Trust (GB), Hospital for Sick Children (CA), Institut Gustave Roussy (FR), University Medical Center Utrecht (NL), University of California San Diego (US), Centre de recherche en Epidémiologie et Santé des Populations (FR), Center for Cancer and Blood Disorders (US), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL), Princess Máxima Center (NL), Foundation Medical Partners (US), Iaso Children’s Hospital (GR), Wilhelmina Children's Hospital (NL), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), Geneva College (US), University of Newcastle Australia (AU), Newcastle University (GB)
Stichting Kinderen Kankervrij
Good health and well-being
Openalex Percentile: Top 11%
Hearing, Cochlea, Tinnitus, Genetics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.